Affiliation:
1. Department of Internal Medicine, School of Veterinary Medicine and Animal Sciences, University of São Paulo, 87 Professor Orlando Marques de Paiva Avenue, São Paulo 05508-010, SP, Brazil
2. Department of Surgery, School of Veterinary Medicine and Animal Sciences, University of São Paulo, 87 Professor Orlando Marques de Paiva Avenue, São Paulo 05508-010, SP, Brazil
3. Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of São Paulo, 225 Duque de Caxias, Pirassununga 13635-900, SP, Brazil
Abstract
The use of recombinant bovine somatotropin (rbST) leads to an increase in variable amounts of milk production in buffalo, but there is a lack of information on the influence of rbST on their metabolism. This study looked at the effects of a single 500 mg dose of rbST on the lipid profile, liver and kidney function, and physical, chemical, and cellular constitution of milk in 14 buffalo over 14 days, from the 100th day of lactation, compared with 14 animals in a control group. From the first day after rbST, there was a rise in beta-hydroxybutyrate (β-HBO), possibly due to higher dry matter intake or the biotransformation of NEFA into β-HBO. The treatment did not influence blood glucose, non-esterified fatty acids (NEFAs), triglycerides, cholesterol, total protein, albumin, AST, GGT, bilirubin, urea, or creatinine levels. In 71.3% of the buffalo, there was a gradual increase in milk production, with the maximal response occurring in the first week followed by a gradual decrease, whilst in 21.4%, the increase in production occurred between 7 and 10 days. Only 7.1% of the animals did not respond. On the 3rd, 5th, 7th, and 10th days after treatment, an increase was found in daily milk production between the two groups equal to 1.04, 1.52, 1.42, and 1.06 L, respectively. In relative terms, this means an increase in milk production, respectively, of 15.1%, 21.0%, 19.8%, and 15.1%. The constitution of the milk showed no difference in the amounts of fat, lactose, total solids, or somatic cell count; however, on the third day after rbST administration, there was a decrease in protein. Notably, from the fifth day, the protein values showed no statistical difference. It can be concluded that the use of rbST in buffalo from the 100th day of lactation is metabolically safe since the treatment neither caused imbalances in fat metabolism nor overloaded the liver or renal function, and the changes in milk composition were transient and limited to a decrease in milk protein.
Funder
São Paulo Research Foundation
Reference46 articles.
1. Valores econômicos para as características de leite de búfalas no estado de São Paulo;Seno;Rev. Bras. Zootec.,2017
2. Jorge, A.M., Couto, A.G., Crudeli, G.A., and Patiño, E.M. (2011). Produção de Búfalas de Leite, FEPAF.
3. Uso de somatotropina bovina em búfalas: Efeitos sobre a produção e composição do leite;Fernandes;Rev. Eletrônica Nutr.,2009
4. Lactation performance of Holstein cows treated with 2 formulations of recombinant bovine somatotropin in a large commercial dairy herd in Brazil;Morais;J. Dairy Sci.,2017
5. Efeito da somatotropina bovina recombinante (Rbst) sobre o desempenho produtivo e reprodutivo de vacas da raça Holandesa;Lucci;Arq. Bras. Med. Veterinária Zootec.,2006